In a bumper week for new biotech financings, debutante Kardigan ruled the roost with a $300 million first round that will ...

N-Power Medicine, backed by Merck GHI, announced the acquisition of Syapse Holdings. Samsung Biologics and LigaChem extended their ADC services deal. Publicis Worldwide merged with Leo Burnett to form ...

Fundings for Seattle-area startups lagged at the end of 2024, according to a new PitchBook-NVCA report, but they're off to a ...

From the Holderness Family to Grandma C, social media personalities around Raleigh and Durham explain what will get lost if ...

Caidya, a clinical research organization (CRO) based in Raleigh, has raised $165 million in private equity to support its growth.

Mysterious Blobs Found inside Cells Are Rewriting the Story of How Life Works Tiny specks called biomolecular condensates are ...

Tune Therapeutics shared a major milestone this week as the Durham startup raised $175 million to fund its first clinical trial. Born at Duke University, Tune has developed a new epigenome editor ...

GlobalData analysts are predicting an Alzheimer’s disease market boom, tipping its value across major regions to increase ...

Apple TV's most anticipated show, Severance, is finally back with its Season 2 after a long wait of three years, and the premiere has raised more questions about the nature of the Macrodata Refinement ...

As multiple novel male contraception compounds enter clinical trials, is family planning about to undergo a second revolution ...